Advertisement

Topics

Metso's Board of Directors decides on payment of extra dividend

20:00 EDT 22 Jul 2015 | Globe Newswire

HELSINKI, Finland, July 23, 2015 (GLOBE NEWSWIRE) -- Metso's Board of Directors has decided to pay an extra dividend of EUR 0.40 per share, using the authorization given by the Annual General Meeting held on March 27, 2015.

The dividend will be paid on August 4, 2015, to shareholders of record in the company's shareholder register maintained by Euroclear Finland Ltd. on the record date of July 27, 2015.

Metso is the world's leading industrial company in the mining and aggregates industries and in the flow control business. Our knowledge, people and solutions help drive sustainable improvements in performance and profitability in our customers' businesses.

Metso has an uncompromising attitude towards safety. Our products range from mining and construction equipment and systems to industrial valves and controls. Our solutions are delivered and supported by decades of process knowledge and a broad scope of services backed by a global footprint of over 90 service centers, thousands of service employees, and an extensive logistics network.

Metso is listed on the NASDAQ OMX Helsinki, Finland. In 2014, Metso's net sales totaled EUR 3.7 billion. Metso employs approximately 14,000 industry experts in more than 50 countries. Expect results.

www.metso.com , www.twitter.com/metsogroup

Further information, please contact:

Juha Rouhiainen, VP, Investor Relations, Metso Corporation, tel +358 20 484 3253

Metso Corporation

Harri Nikunen

CFO

Juha Rouhiainen

VP, Investor Relations

Distribution:

NASDAQ OMX Helsinki Ltd

Media

www.metso.com

HUG#1940752

NEXT ARTICLE

More From BioPortfolio on "Metso's Board of Directors decides on payment of extra dividend"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...